Leveraging Development Strengths Drives Therapies to Market

Publication
Article
BioPharm InternationalBioPharm International-12-16-2013
Volume 2013 eBook
Issue 1

NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

 

Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

Read this article from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

View other articles in the 2013 Innovation Updates and Strategies eBook.

 

 

 

 

Articles in this issue
BPsupp1213_AmbrexProfile_200.jpg
Creating Better Medicines through Better Conjugation
BPsupp1213_Patent_200.jpg
Recovering Patent Life with Patent Term Extension
BPsupp1213_Vetter_200.jpg
Strategic Outsourcing in Clinical Development
BPsupp1213_NPSPharma_200.jpg
Leveraging Development Strengths Drives Therapies to Market
BPsupp1213_Kalypso_200.jpg
Driving Innovation in Biopharmaceuticals
BPsupp1213_Crowdfunding_200.jpg
Crowdfunding Biopharmaceutical Innovation
BPsupp1213_Merck_serono_200.jpg
Restructuring for Biopharmaceutical Success
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Cancer in the blood outbreak and treatment for malignant cells in a human body caused by carcinogens and genetics with a cancerous cell as an immunotherapy and leukemia or lymphoma symbol and medical | Image Credit: © freshidea - stock.adobe.com

Multiple Myeloma Treatment from Regeneron Gets FDA Accelerated Approval

Patrick Lavery
July 2nd 2025
Article

Linvoseltamab-gcpt, marketed as Lynozyfic, is a bispecific antibody designed to facilitate T cell activation and cancer cell killing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EDQM Announces Digital Version of the European Pharmacopoeia

Susan Haigney
June 26th 2025
Article

EDQM is providing the 12th edition of the European Pharmacopoeia as an all-digital, redesigned, user-friendly issue.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA Conditionally Authorizes Stem Cell Therapy for Blood Cancers

Susan Haigney
June 23rd 2025
Article

The agency has recommended conditional marketing authorization for Zemcelpro (dorocubicel/unexpanded umbilical cord cells) to treat adults with hematological malignancies (blood cell cancers).

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | Image Credit: © Tada Images - stock.adobe.com

FDA Halts Clinical Trials That Send US Patient Cells to Foreign Labs

Patrick Lavery
June 20th 2025
Article

Some of the companies that received American samples, FDA said, are partially owned or controlled by the Communist Party in China.

Bioreactor. Cultivation of microorganisms in the bioreactor. Laboratory fermenter. Microbial fermentation. The creation of drugs. Microbiology. Biotech industry. Pharmacology. | Image Credit: © Grispb - stock.adobe.com

Aragen to Commence GMP Manufacturing at India Biologics Facility in July 2025

Patrick Lavery
June 16th 2025
Article

The company’s successful completion of facility and equipment qualifications gives it another biologics manufacturing option alongside its United States campus in Morgan Hill, Calif.

Close-up of gloved hands in a cleanroom meticulously wiping a stainless steel surface. Maintaining sterility is paramount in this precise environment. | Image Credit: ©Aditya – stock.adobe.com

Considerations for Quality Improvement of Cleaning, Disinfection, and Cleaning Validation in Biopharmaceutical Manufacturing, Part I: Facility and Cleanroom Cleaning Practices

Thomas Altmann;Donald Singer;Stefan-Julian Frohberger
June 6th 2025
Article

This paper highlights considerations based on risk that ensure ongoing success as well as improvement when applying cleaning and decontamination principles for biopharmaceutical cleanroom surfaces.

© 2025 MJH Life Sciences

All rights reserved.